Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial–mesenchymal transition, and metastasis in FGFR1-amplified lung cancer
Kaixuan Wang, Wenxiang Ji, Yongfeng Yu, et al.
Oncogene (2018) Vol. 37, Iss. 39, pp. 5340-5354
Closed Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

The role of SOX family members in solid tumours and metastasis
Daniela Grimm, Johann Bauer, Petra M. Wise, et al.
Seminars in Cancer Biology (2019) Vol. 67, pp. 122-153
Open Access | Times Cited: 339
Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells
Pengfei Zhang, Xu Pei, Kesang Li, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 208
Mutational drivers of cancer cell migration and invasion
Nikita M. Novikov, Sofia Y. Zolotaryova, Alexis Gautreau, et al.
British Journal of Cancer (2020) Vol. 124, Iss. 1, pp. 102-114
Open Access | Times Cited: 200
SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyond
Thorsten Schaefer, Claudia Lengerke
Oncogene (2019) Vol. 39, Iss. 2, pp. 278-292
Open Access | Times Cited: 164
Functional characterization of SOX2 as an anticancer target
Shizhen Zhang, Xiufang Xiong, Yi Sun
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 155
The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges
Shimin Xie, Zhengguo Wu, Yi Qi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111450-111450
Open Access | Times Cited: 116
The Role of Myofibroblasts in Physiological and Pathological Tissue Repair
Ronen Schuster, Fereshteh S. Younesi, Maya Ezzo, et al.
Cold Spring Harbor Perspectives in Biology (2022) Vol. 15, Iss. 1, pp. a041231-a041231
Open Access | Times Cited: 106
New developments in the biology of fibroblast growth factors
David M. Ornitz, Nobuyuki Itoh
WIREs Mechanisms of Disease (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 96
Rare molecular subtypes of lung cancer
Guilherme Harada, Soo‐Ryum Yang, Emiliano Cocco, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 4, pp. 229-249
Open Access | Times Cited: 73
The FGF/FGFR System in Breast Cancer: Oncogenic Features and Therapeutic Perspectives
Maria Francesca Santolla, Marcello Maggiolini
Cancers (2020) Vol. 12, Iss. 10, pp. 3029-3029
Open Access | Times Cited: 80
Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
Yue Zheng, Laduona Wang, Limei Yin, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 64
FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
Jakub Szymczyk, Katarzyna Dominika Sluzalska, Izabela Materla, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5796-5796
Open Access | Times Cited: 61
Characterizing DNA methylation signatures of retinoblastoma using aqueous humor liquid biopsy
Hongtao Li, Liya Xu, Daniel J. Weisenberger, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 49
SOX2 function in cancers: Association with growth, invasion, stemness and therapy response
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Maliheh Entezari, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113860-113860
Closed Access | Times Cited: 40
Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs
Xing Peng, Shuo Wang, Yu Cao, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101002-101002
Open Access | Times Cited: 23
Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways
Maya R. MacLean, Olivia L. Walker, Raj Pranap Arun, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4102-4102
Open Access | Times Cited: 15
Hypoxia Induces Resistance to EGFR Inhibitors in Lung Cancer Cells via Upregulation of FGFR1 and the MAPK Pathway
Yuhong Lü, Yanfeng Liu, Sebastian Oeck, et al.
Cancer Research (2020) Vol. 80, Iss. 21, pp. 4655-4667
Open Access | Times Cited: 66
Cancer Stem Cells in Neuroblastoma: Expanding the Therapeutic Frontier
Hisham F. Bahmad, Farah Chamaa, Sahar Assi, et al.
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 60
GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression
Maria Francesca Santolla, Adele Vivacqua, Rosamaria Lappano, et al.
Cells (2019) Vol. 8, Iss. 3, pp. 223-223
Open Access | Times Cited: 56
S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1/2 pathways
Dan Fang, Chengfei Zhang, Ping Xu, et al.
Cell Biology and Toxicology (2021) Vol. 37, Iss. 4, pp. 555-571
Closed Access | Times Cited: 44
LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non‐small cell lung cancer
Yanping Gao, Nannan Zhang, Zihang Zeng, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 37
Targeting Extracellular Signal-Regulated Protein Kinase 1/2 (ERK1/2) in Cancer: An Update on Pharmacological Small-Molecule Inhibitors
Leilei Fu, Siwei Chen, Gu He, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 20, pp. 13561-13573
Closed Access | Times Cited: 29
CXCL14 promotes metastasis of non-small cell lung cancer through ACKR2-depended signaling pathway
Tsung‐Ming Chang, Yao‐Chang Chiang, Chiang‐Wen Lee, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 5, pp. 1455-1470
Open Access | Times Cited: 20
SOX2-associated signaling pathways regulate biological phenotypes of cancers
Li Ding, Youlin Yu, Chao Ma, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114336-114336
Open Access | Times Cited: 18
The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention
Subhasmita Mahapatra, Nisha Amarnath Jonniya, Suman Koirala, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 22, pp. 13509-13533
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top